Scooting past analyst estimates for its latest quarter gave (NYSE: NVS) a lift on Tuesday. Investors like what they heard about the global healthcare company's inaugural earnings release for 2024, and rewarded Novartis with a more than 2% lift in its stock price today. The shares did better than the S 500 index, which had a relatively good trading session with a 1.2% gain.

In its first quarter, Novartis managed to boost net sales by 11% year over year to $11.8 billion. The pharmaceutical company's core net income rose by 14% to hit $3.68 billion ($1.80 per share).

Both headline figures came in above the average analyst estimates. Collectively, prognosticators tracking the company were anticipating it would post net sales of $11.43 billion, and a per-share core net income of $1.67.

Continue reading

Source Fool.com